APF
AGIO icon

Alaska Permanent Fund’s Agios Pharmaceuticals AGIO Stock Holding History

Alaska Permanent Fund’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44,700
Closed -$1.3M – 406
2022
Q1 		$1.3M Hold
44,700
– – 0.02% 207
2021
Q4 		$1.38M Hold
44,700
– – 0.03% 211
2021
Q3 		$2.06M Hold
44,700
– – 0.04% 196
2021
Q2 		$2.46M Buy
+44,700
New +$2.5M 0.05% 102

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Alaska Permanent Fund's AGIO Position: Q2 2022 in Review

Alaska Permanent Fund sold out of Agios Pharmaceuticals (AGIO) in Q2 2022, closing a stake of 44,700 shares — an estimated $1.3M sold.

Alaska Permanent Fund first reported a position in AGIO in Q2 2021 and held it in 4 quarters. The position peaked at $2.46M in Q2 2021. 156 funds tracked by Wall St. Rank hold AGIO as of Q2 2022.

  • Alaska Permanent Fund reported no remaining Agios Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Alaska Permanent Fund sold 44,700 Agios Pharmaceuticals shares in Q2 2022, an estimated $1.3M.
  • Alaska Permanent Fund first reported a position in Agios Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Alaska Permanent Fund's Agios Pharmaceuticals position peaked at $2.46M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2022.

Based on Alaska Permanent Fund's 13F filing for Q2 2022, filed 9 Aug 2022.